All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Originally posted by @jennekeheyligers on TikTok · 124s|Watch on TikTok

Does Ozempic really cause 50% muscle loss? We checked

Jen | online weightloss coach

TikTok creator

87.6K viewsWatch on TikTok

Quick answer

GLP-1 receptor agonists like semaglutide slow gastric emptying and reduce appetite through hypothalamic pathways. The STEP 1 trial showed 14.9% weight loss with 2.4mg semaglutide over 68 weeks, with roughly 25% of lost weight coming from lean body mass. This muscle loss percentage is typical for rapid weight loss interventions.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

GLP-1 social video fact-checksCompounded SemaglutideProvider discussion

Evidence signal

Source-backed review

Regulatory reality

Compounded Semaglutide access requires the right clinical path

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 6 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For Does Ozempic really cause 50% muscle loss? We checked, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Video claim decision path

Turn the claim into a safer next question

Direct answer

Compounded Semaglutide should be treated as a claim to verify, then compared with evidence, safety context, and a provider review path.

Evidence check

Social clips are useful prompts, but they rarely show the full evidence base, contraindications, or dosing context.

Safety check

A viral claim can miss patient-specific risks, medication interactions, legal access, and source quality.

Next step

If the claim matches your goal, use the get-started flow to move from curiosity into a supervised prescription review.

Claim path

Keep researching this semaglutide video claims cluster

Best for searchers comparing social semaglutide claims with GLP-1 eligibility, outcomes, and safety context.

Page-specific review note

What this exact clip is really saying

This FormBlends review is specific to "Does Ozempic really cause 50% muscle loss? We checked" from Jen | online weightloss coach. We read the clip as a GLP-1 social video fact-checks claim about Compounded Semaglutide, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: GLP-1 receptor agonists like semaglutide slow gastric emptying and reduce appetite through hypothalamic pathways.

The reason this review is not generic is the source wording and the canonical claim label "glp1 ozempic laat je afvallen maar niemand vertelt je dat 20 to." In this clip, the useful excerpt is: "Ozempic laat je afvallen — maar niemand vertelt je dat 20 tot 50 procent van dat gewichtsverlies spiermassa kan zijn." That wording changes the review because it points to Compounded Semaglutide safety, access, evidence, and fit, not a one-size-fits-all protocol.

The source trail for this page is checked against Once-Weekly Semaglutide in Adults with Overweight or Obesity (2021), Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance (2021), and Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight (2022), plus the creator's own wording. Compounded Semaglutide still needs an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.

Lean body mass includes water, organs, and connective tissue, not just skeletal muscle
People who land here are usually comparing the Compounded Semaglutide claim with [object Object].
The strongest next step is to compare the claim with FormBlends' Compounded Semaglutide guide, evidence notes, and provider review path before acting.

Claim verdict

The useful answer behind this video

This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.

Claim being checked

GLP-1 receptor agonists like semaglutide slow gastric emptying and reduce appetite through hypothalamic pathways.

FormBlends verdict

Compounded Semaglutide safety, access, evidence, and fit

Evidence strength

Source-backed review with clinical or regulatory citations.

Patient-safe next step

Compare the claim with the Compounded Semaglutide guide, safety notes, access rules, and a licensed-provider review.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • GLP-1 receptor agonists like semaglutide slow gastric emptying and reduce appetite through hypothalamic pathways. The STEP 1 trial showed 14.9% weight loss with 2.4mg semaglutide over 68 weeks, with roughly 25% of lost weight coming from lean body mass. This muscle loss percentage is typical for rapid weight loss interventions.
  • STEP 1 trial data shows about 25% of semaglutide weight loss comes from lean body mass, not the 50% claimed
  • Lean body mass includes water, organs, and connective tissue, not just skeletal muscle

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • Compounded Semaglutide decisions still need source quality, legal access, and provider oversight checks.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against the Compounded Semaglutide guide, cost path, safety notes, and provider review before acting.

Review Compounded Semaglutide

What You'll Learn

  • STEP 1 trial data shows about 25% of semaglutide weight loss comes from lean body mass, not the 50% claimed
  • Lean body mass includes water, organs, and connective tissue, not just skeletal muscle
  • All rapid weight loss methods cause some muscle loss, not just GLP-1 receptor agonists
  • Resistance training combined with adequate protein intake can minimize muscle loss during weight loss
  • SELECT trial showed semaglutide reduced cardiovascular events by 20% in people with obesity
  • Protein intake of 1.2-1.6g per kg body weight may help preserve muscle during GLP-1 treatment
  • The coach's core message about muscle preservation is correct, but her statistics are inflated

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.

What does this TikTok coach actually claim?

Jenneke Heyligers tells her 87,600 viewers that Ozempic causes 20-50% of weight loss to come from muscle mass, not fat. She argues this muscle loss slows metabolism and worsens insulin regulation after age 40.

The video cuts off mid-sentence but appears to reference research showing women on GLP-1 drugs who don't do resistance training lose 40% more muscle than those who do. She frames this as a major problem that "nobody tells you about."

Her core message: muscle preservation should be your top priority when using semaglutide for weight loss.

What does the research actually show?

The muscle loss claim has some basis in science, but her numbers are inflated. The STEP 1 trial (Wilding et al., NEJM, 2021) found that people taking 2.4mg semaglutide lost 14.9% of their body weight over 68 weeks.

A follow-up analysis using DEXA scans showed roughly 25% of that weight loss came from lean body mass. That's meaningful but nowhere near her claimed 50%.

The SURMOUNT-1 trial (Jastreboff et al., NEJM, 2022) found similar patterns with tirzepatide. People lost 20.9% of body weight at the highest dose, with about 20-25% coming from lean tissue. This isn't unique to GLP-1 drugs. Any significant calorie restriction causes some muscle loss.

Where did she go wrong?

Heyligers cherry-picked the worst-case scenario and presented it as typical. Her 20-50% range takes outlier data points and makes them sound standard.

She also doesn't mention that "lean body mass" includes water, connective tissue, and organs, not just skeletal muscle. The actual skeletal muscle loss is smaller than her numbers suggest.

Her claim about women losing "40% more muscle" without resistance training is impossible to verify since she doesn't name the study. We searched recent literature and couldn't find research matching that specific claim.

What did she get right?

She's absolutely correct that muscle preservation matters during weight loss. The Cataneo study (Obesity, 2021) showed people who combined resistance training with calorie restriction maintained more lean mass than those who just dieted.

Her point about metabolism is also valid. Lean tissue burns more calories at rest than fat tissue, so muscle loss can slow your metabolic rate.

The age 40 threshold she mentions matches research showing sarcopenia (age-related muscle loss) accelerates around that age. Starting with less muscle makes preservation even more important.

What should you actually know?

GLP-1 drugs do cause some muscle loss, but it's not the disaster this video suggests. Most weight loss methods cause lean tissue loss when people lose weight quickly without exercise.

The solution isn't avoiding these medications. It's combining them with resistance training and adequate protein intake. The recent SELECT trial (Ryan et al., NEJM, 2023) showed semaglutide reduced cardiovascular events by 20% in people with obesity.

If you're considering semaglutide or tirzepatide, discuss muscle preservation strategies with your doctor. That might include strength training, protein targets around 1.2-1.6g per kg of body weight, and possibly slower weight loss rates.

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

Jen | online weightloss coach · TikTok creator

87.6K views on this video

Ozempic laat je afvallen — maar niemand vertelt je dat 20 tot 50 procent van dat gewichtsverlies spiermassa kan zijn. Dat is geen detail. Dat is een probleem. Spiermassa is na je veertigste je groots

Frequently asked questions

Quick answers based on this video and our medical team review.

What does the video say about step 1 trial data shows about 25% of semaglutide weight?

STEP 1 trial data shows about 25% of semaglutide weight loss comes from lean body mass, not the 50% claimed

What does the video say about lean body mass includes water,?

Lean body mass includes water, organs, and connective tissue, not just skeletal muscle

What does the video say about all rapid weight loss methods cause some muscle loss, not?

All rapid weight loss methods cause some muscle loss, not just GLP-1 receptor agonists

What does the video say about resistance training combined with adequate protein intake can minimize muscle?

Resistance training combined with adequate protein intake can minimize muscle loss during weight loss

What does the video say about select trial showed semaglutide reduced cardiovascular events by 20% in?

SELECT trial showed semaglutide reduced cardiovascular events by 20% in people with obesity

What does the video say about protein intake of 1.2-1.6g per kg body weight may help?

Protein intake of 1.2-1.6g per kg body weight may help preserve muscle during GLP-1 treatment

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Read More on This Topic

Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.

Not medical advice. This video was made by Jen | online weightloss coach, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.